Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.05
Bid: 2.90
Ask: 3.20
Change: -0.05 (-1.61%)
Spread: 0.30 (10.345%)
Open: 3.10
High: 3.10
Low: 3.05
Prev. Close: 3.10
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo

Wed, 28th Apr 2021 15:30

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Deliveroo PLC - London-based takeaway food delivery service - Hires Dominique Reiniche and Karen Jones as non-executive directors. Reiniche was president and then chair of the Europe Group of Coca-Cola Co. She is a non-executive director of packaging firm Mondi PLC and currently a non-executive director of Severn Trent PLC, though is set to step down from the water utility's board. Reiniche also is chair of Eurostar. Jones was founder of restaurant chain Cafe Rouge and currently is chair of steak house Hawskmoor and executive chair of pasta house Prezzo.

----------

FIH Group PLC - provider of retail, transport and logistics services in UK and Falkland Islands - Hires Stuart Munro as chief financial officer, starting Wednesday. Munro has worked as a finance director in infrastructure and transport firms such as Balfour Beatty PLC, Alfred McAlpine Infrastructure Services, FirstGroup PLC and Transport for London.

----------

Wickes Group PLC - United Utilities Group PLC, Grainger PLC and Aggreko PLC note that Mark Clare, a non-executive director for all three, has been appointed as senior independent non-executive director of Wickes, as the spin-off from Travis Perkins PLC starts trading on London Main Market on Wednesday. Pets At Home Group PLC notes that Chief Financial Officer Mike Iddon is a non-executive director of Wickes.

----------

Tate & Lyle PLC - Hires Patricia Corsi as non-executive director, starting May 1. Corsi is global chief marketing & digital officer for Bayer Consumer Health, part of Bayer AG. Previously she worked for brewer Heineken NV and consumer goods firms Unilever PLC and Kraft Foods, part of Kraft Heinz Co. As previously announced, Anne Minto will retire at the July 29 annual general meeting.

----------

Redcentric PLC - Harrogate, North Yorkshire-based IT managed services - Non-Executive Director Steve Vaughan steps down from board, effective immediately, "to focus on other interests". Redcentric says it has started a review of board composition.

----------

Boston International Holdings PLC - special purpose acquisitions company - Hires Christopher Pitman as chair and Martin Lampshire as non-executive director, effective immediately. Pitman is a petroleum geologist with 35 years exploration and production experience, BIH says, while Lampshire is a broker who is executive director of Global Resources Investment Trust PLC and non-executive director of Bould Opportunities PLC and ValiRx PLC. BIH also says it is delaying its 2020 accounts to no later than June 30.

----------

AFC Energy PLC - Surrey-based hydrogen power generation technology - Hires David Harvey as chief technology officer, starting in May. Harvey was senior research engineer at Ballard Power Systems and head of Fuel Cell Development at Fuel Cell Powertrain GmbH. He is relocating to the UK to take the job.

----------

B90 Holdings PLC - Isle of Man-based sportsbook operator and online marketing gaming - Rainer Lauffs to step down as chief operating officer and from board in six months time, following a handover. Ronny Breivik is hired to be CEO of main operating subsidiary B90 Ventures Ltd, joining initially as a consultant. Brievik has worked in online gaming since 1997 and launched the first gaming portal in Norway, B90 says. Brievik will be issued 280,000 shares as his initial fee, followed by a further 280,000 on June 30. B90 was quoted at 13.00 pence on Wednesday afternoon, making the 560,000 shares worth GBP72,800.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Feb 2021 11:05

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

Read more
19 Jan 2021 16:53

IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer

IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer

Read more
10 Nov 2020 17:40

UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter

UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter

Read more
23 Sep 2020 19:09

UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges

UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges

Read more
7 Sep 2020 11:55

ValiRx Loss Narrows In First Half Amid Reduction In Expenses

ValiRx Loss Narrows In First Half Amid Reduction In Expenses

Read more
24 Jul 2020 17:23

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

Read more
23 Jul 2020 18:02

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

Read more
16 Jul 2020 15:57

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
6 Jul 2020 18:19

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

Read more
6 Jul 2020 09:31

ValiRx looks to build on portfolio of drug candidates

(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.

Read more
1 Jul 2020 13:10

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

Read more
16 Jun 2020 13:58

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

Read more
8 Jun 2020 15:39

ValiRx Delays Annual Results Amid Covid-19 Pandemic

ValiRx Delays Annual Results Amid Covid-19 Pandemic

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
2 Jun 2020 12:03

ValiRx enters collaboration agreement for Covid-19 treatment

(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.